You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 10,064,857


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,064,857
Title:Bupropion as a modulator of drug activity
Abstract: Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Inventor(s): Tabuteau; Herriot (New York, NY)
Assignee: ANTECIP BIOVENTURES II LLC (New York, NY)
Application Number:15/691,549
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,064,857: A Comprehensive Guide

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for inventors, researchers, and business professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 10,064,857, using various tools and resources available for patent searches.

Understanding Patent Scope and Claims

Before diving into the specifics of Patent 10,064,857, it is essential to understand what patent scope and claims entail.

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count, which can indicate the complexity and breadth of the patent[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of protection. They are typically divided into independent and dependent claims, with independent claims standing alone and dependent claims referring back to an independent claim.

United States Patent 10,064,857 Overview

Patent Details

  • Patent Number: 10,064,857
  • Title: Bupropion as a Modulator of Drug Activity
  • Publication Date: This patent is part of a series of applications, with the most recent continuation being US11426401B2, indicating ongoing development and refinement of the invention[5].

Prior Art and Related Applications

The patent is a continuation of earlier applications, such as U.S. patent application Ser. No. 15/224,233, which was filed on July 29, 2016, and is now abandoned. This indicates that the inventors have been refining their claims over time[5].

Analyzing the Claims

Independent Claims

Independent claims in Patent 10,064,857 define the core invention. For example, claims might include specific formulations or methods of using bupropion to modulate drug activity. These claims are critical as they set the boundaries of what is protected under the patent.

Dependent Claims

Dependent claims build upon the independent claims, often adding specific details or limitations. These claims help to narrow down the scope and provide additional protection for specific aspects of the invention.

Scope of the Patent

Metrics for Measuring Scope

Research suggests that metrics such as independent claim length and count can be used to measure patent scope. For Patent 10,064,857, analyzing these metrics can provide insights into the breadth and complexity of the claims. Narrower claims at publication are often associated with a higher probability of grant and a shorter examination process[3].

Breadth of Protection

The scope of Patent 10,064,857 would be determined by the language used in the claims. If the claims are broad, they may cover a wide range of applications and formulations involving bupropion. However, broader claims may face more scrutiny during the examination process.

Patent Landscape

Related Patents and Applications

To understand the patent landscape surrounding Patent 10,064,857, it is necessary to search for related patents and applications. Tools like the USPTO's Patent Public Search, Google Patents, and international databases such as Espacenet and PATENTSCOPE can be used to identify similar inventions and prior art[1][4].

Global Dossier and Common Citation Document (CCD)

Using the Global Dossier and CCD tools, one can access the file histories of related applications from participating IP Offices. This helps in identifying the patent family and any office actions or citations that might affect the scope of the patent[1].

Search and Analysis Tools

USPTO Resources

The USPTO provides several resources for searching patents, including the Patent Public Search tool, which offers modern interfaces for enhanced access to prior art. The Public Search Facility and Patent and Trademark Resource Centers (PTRCs) also offer assistance in conducting thorough patent searches[1].

International Databases

Databases such as Espacenet (European Patent Office), PATENTSCOPE (World Intellectual Property Organization), and national patent offices' databases (e.g., Japan Patent Office, China National Intellectual Property Administration) are essential for a global patent landscape analysis[1][4].

Practical Steps for Analysis

Step-by-Step Search Strategy

  1. Use the Patent Public Search Tool: Start with the USPTO's Patent Public Search to find the patent and related documents.
  2. Access Global Dossier: Use the Global Dossier to view the file histories and related applications from participating IP Offices.
  3. Analyze Claims: Carefully read and analyze the independent and dependent claims to understand the scope of protection.
  4. Search International Databases: Use international databases to identify similar patents and prior art.
  5. Consult PTRCs: If needed, consult with staff at PTRCs for additional guidance on patent search techniques.

Key Takeaways

  • Understand Patent Scope and Claims: The scope and claims of a patent define its protection boundaries.
  • Use Advanced Search Tools: Utilize tools like the USPTO's Patent Public Search, Global Dossier, and international databases for comprehensive analysis.
  • Analyze Metrics: Metrics such as independent claim length and count can provide insights into the breadth and complexity of the patent.
  • Consult Resources: Leverage resources like PTRCs and the USPTO Public Search Facility for assistance.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the core invention and set the boundaries of what is protected under the patent. They are crucial for understanding the scope of protection.

Q: How can I measure the scope of a patent?

A: Metrics such as independent claim length and count can be used to measure patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process.

Q: What tools can I use to search for related patents and applications?

A: Tools like the USPTO's Patent Public Search, Google Patents, Espacenet, and PATENTSCOPE can be used to identify related patents and applications.

Q: Why is it important to analyze the patent landscape?

A: Analyzing the patent landscape helps in identifying similar inventions, prior art, and potential office actions or citations that might affect the scope of the patent.

Q: Where can I get assistance with patent search techniques?

A: You can get assistance from staff at the USPTO Public Search Facility or your nearest Patent and Trademark Resource Center (PTRC).

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Patent search: A comparative table of databases - Fast Answers: https://asklib.library.hbs.edu/faq/266950
  5. US11426401B2 - Bupropion as a modulator of drug activity - Google Patents: https://patents.google.com/patent/US11426401B2/en

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,064,857

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome AUVELITY bupropion hydrochloride; dextromethorphan hydrobromide TABLET, EXTENDED RELEASE;ORAL 215430-001 Aug 18, 2022 RX Yes Yes 10,064,857 ⤷  Try for Free DEXTROMETHORPHAN AND BUPROPION IN COMBINATION TO TREAT MAJOR DEPRESSIVE DISORDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.